Daniel D Buchanan
Overview
Explore the profile of Daniel D Buchanan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
260
Citations
7199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alduhayh S, Laskar R, Jiang X, Zhu Z, Vincent E, Constantinescu A, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Feb;
PMID: 39982694
Background: Tumor immunosurveillance theory supports that allergic conditions could decrease cancer risk. However, observational evidence yielded inconsistent results for the association between allergic diseases and colorectal cancer risk. We used...
2.
Chalitsios C, Markozannes G, Papagiannopoulos C, Aglago E, Berndt S, Buchanan D, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Feb;
PMID: 39898780
Background Waist circumference (WC) and its allometric counterpart, "a body shape index" (ABSI), are risk factors for colorectal cancer (CRC); however, it is uncertain whether associations with these body measurements...
3.
Moller P, Ahadova A, Kloor M, Seppala T, Burn J, Haupt S, et al.
Hered Cancer Clin Pract
. 2025 Jan;
23(1):3.
PMID: 39849512
Carcinogenesis encompasses processes that lead to increased mutation rates, enhanced cellular division (tumour growth), and invasive growth. Colorectal cancer (CRC) carcinogenesis in carriers of pathogenic APC (path_APC) and pathogenic mismatch...
4.
Prizment A, Standafer A, Qu C, Beutel K, Wang S, Huang W, et al.
Hum Mol Genet
. 2025 Jan;
PMID: 39825500
Background: Individuals with cystic fibrosis (CF; a recessive disorder) have an increased risk of colorectal cancer (CRC). Evidence suggests individuals with a single CFTR variant may also have increased CRC...
5.
Walker R, Joo J, Mahmood K, Clendenning M, Como J, Preston S, et al.
Transl Oncol
. 2025 Jan;
52:102266.
PMID: 39793275
Background: Colorectal cancers (CRCs) from people with biallelic germline likely pathogenic/pathogenic variants in MUTYH or NTHL1 exhibit specific single base substitution (SBS) mutational signatures, namely combined SBS18 and SBS36 (SBS18+SBS36),...
6.
Walker R, Joo J, Mahmood K, Georgeson P, Winship I, Buchanan D
Gastroenterology
. 2025 Jan;
PMID: 39788211
No abstract available.
7.
Thomas C, Takashima Y, Wesselink E, Ugai T, Steinfelder R, Buchanan D, et al.
Front Immunol
. 2025 Jan;
15:1505896.
PMID: 39763680
Background: Microsatellite instability-high (MSI-high) tumors comprise ~15% of sporadic colorectal cancers (CRC) and are associated with elevated T cell infiltration. However, the universality of this response across T cell subtypes...
8.
MacInnis R, Jenkins M, Milne R, John E, Daly M, Andrulis I, et al.
JNCI Cancer Spectr
. 2024 Dec;
9(1).
PMID: 39673461
Menopausal users of hormone replacement therapy (HRT) are at increased breast cancer risk and decreased colorectal cancer (CRC) risk compared with individuals who have never used HRT, but these opposing...
9.
Correa-Medero R, Pai R, Ebare K, Buchanan D, Jenkins M, Phipps A, et al.
PLoS One
. 2024 Nov;
19(11):e0303415.
PMID: 39576760
Advancement of AI has opened new possibility for accurate diagnosis and prognosis using digital histopathology slides which not only saves hours of expert effort but also makes the estimation more...
10.
McGee H, Bonner J, Egelston C, Fu Y, Flores O, Lindsey S, et al.
medRxiv
. 2024 Oct;
PMID: 39464256
The incidence of colorectal cancer (CRC) among individuals under age 50, or early-onset CRC (EOCRC), has been rising over the past few decades for unclear reasons, and the etiology of...